Ken Herrmann

Summary

Country: Germany

Publications

  1. doi request reprint Monitoring response to therapeutic interventions in patients with cancer
    Ken Herrmann
    Department of Nuclear Medicine, Technische Universitat Munchen, Munich, Germany
    Semin Nucl Med 39:210-32. 2009
  2. doi request reprint Comparison of different SUV-based methods for response prediction to neoadjuvant radiochemotherapy in locally advanced rectal cancer by FDG-PET and MRI
    Ken Herrmann
    Department of Nuclear Medicine, Klinikum rechts der Isar der Technischen Universitat Munchen, Munich, Germany
    Mol Imaging Biol 13:1011-9. 2011
  3. doi request reprint Predictive value of initial 18F-FLT uptake in patients with aggressive non-Hodgkin lymphoma receiving R-CHOP treatment
    Ken Herrmann
    Department of Nuclear Medicine, Technische Universitaet Muenchen, Munich, Germany
    J Nucl Med 52:690-6. 2011
  4. doi request reprint Imaging of proliferation in hepatocellular carcinoma with the in vivo marker 18F-fluorothymidine
    Florian Eckel
    Department of Internal Medicine II, Technische Universitat Munchen, Munich, Germany
    J Nucl Med 50:1441-7. 2009
  5. doi request reprint [18F]FLT is superior to [18F]FDG for predicting early response to antiproliferative treatment in high-grade lymphoma in a dose-dependent manner
    Nicolas Graf
    Department of Hematology Oncology, Technische Universitat Munchen, Munich, Germany
    Eur J Nucl Med Mol Imaging 40:34-43. 2013
  6. ncbi request reprint Prediction of tumor response by FDG-PET: comparison of the accuracy of single and sequential studies in patients with adenocarcinomas of the esophagogastric junction
    Hinrich A Wieder
    Department of Nuclear Medicine, Klinikum rechts der Isar, Technische Universitaet Muenchen, Ismaningerstrasse 22, Munich, Germany
    Eur J Nucl Med Mol Imaging 34:1925-32. 2007
  7. doi request reprint Early metabolic response evaluation by fluorine-18 fluorodeoxyglucose positron emission tomography allows in vivo testing of chemosensitivity in gastric cancer: long-term results of a prospective study
    Katja Ott
    Department of Surgery, Technische Universitat Munchen, Munich, Germany
    Clin Cancer Res 14:2012-8. 2008
  8. ncbi request reprint PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial
    Florian Lordick
    Department of Surgery, Clinic rechts der Isar, Technical University of Munich, Munich, Germany
    Lancet Oncol 8:797-805. 2007
  9. doi request reprint [(11)C]Choline positron emission tomography/computed tomography for staging and restaging of patients with advanced prostate cancer
    Murat Tuncel
    Department of Nuclear Medicine, Klinikum rechts der lsar, Technische Universitat Munchen, Munich, Germany
    Nucl Med Biol 35:689-95. 2008
  10. doi request reprint A pilot study to evaluate 3'-deoxy-3'-18F-fluorothymidine pet for initial and early response imaging in mantle cell lymphoma
    Ken Herrmann
    Department of Nuclear Medicine, Technische Universitat Munchen, Munich, Germany
    J Nucl Med 52:1898-902. 2011

Detail Information

Publications64

  1. doi request reprint Monitoring response to therapeutic interventions in patients with cancer
    Ken Herrmann
    Department of Nuclear Medicine, Technische Universitat Munchen, Munich, Germany
    Semin Nucl Med 39:210-32. 2009
    ..In addition, the future direction of research and clinical applications is discussed...
  2. doi request reprint Comparison of different SUV-based methods for response prediction to neoadjuvant radiochemotherapy in locally advanced rectal cancer by FDG-PET and MRI
    Ken Herrmann
    Department of Nuclear Medicine, Klinikum rechts der Isar der Technischen Universitat Munchen, Munich, Germany
    Mol Imaging Biol 13:1011-9. 2011
    ....
  3. doi request reprint Predictive value of initial 18F-FLT uptake in patients with aggressive non-Hodgkin lymphoma receiving R-CHOP treatment
    Ken Herrmann
    Department of Nuclear Medicine, Technische Universitaet Muenchen, Munich, Germany
    J Nucl Med 52:690-6. 2011
    ....
  4. doi request reprint Imaging of proliferation in hepatocellular carcinoma with the in vivo marker 18F-fluorothymidine
    Florian Eckel
    Department of Internal Medicine II, Technische Universitat Munchen, Munich, Germany
    J Nucl Med 50:1441-7. 2009
    ..We determined the ability of PET with the thymidine analog 3'-deoxy-3'-(18)F-fluorothymidine ((18)F-FLT) to detect hepatocellular carcinoma (HCC)...
  5. doi request reprint [18F]FLT is superior to [18F]FDG for predicting early response to antiproliferative treatment in high-grade lymphoma in a dose-dependent manner
    Nicolas Graf
    Department of Hematology Oncology, Technische Universitat Munchen, Munich, Germany
    Eur J Nucl Med Mol Imaging 40:34-43. 2013
    ..In this preclinical in vitro and in vivo study we compared [(18)F]FLT to the glucose analogue [(18)F]fluorodeoxyglucose ([(18)F]FDG) regarding dose-dependent visualization and prediction of early therapy response...
  6. ncbi request reprint Prediction of tumor response by FDG-PET: comparison of the accuracy of single and sequential studies in patients with adenocarcinomas of the esophagogastric junction
    Hinrich A Wieder
    Department of Nuclear Medicine, Klinikum rechts der Isar, Technische Universitaet Muenchen, Ismaningerstrasse 22, Munich, Germany
    Eur J Nucl Med Mol Imaging 34:1925-32. 2007
    ..To address this question we studied the time course of changes in tumor FDG-uptake in patients with locally advanced adenocarcinomas of the esophagogastric junction (AEG) treated with preoperative chemotherapy...
  7. doi request reprint Early metabolic response evaluation by fluorine-18 fluorodeoxyglucose positron emission tomography allows in vivo testing of chemosensitivity in gastric cancer: long-term results of a prospective study
    Katja Ott
    Department of Surgery, Technische Universitat Munchen, Munich, Germany
    Clin Cancer Res 14:2012-8. 2008
    ..The goal of the study was the definition of biologically different groups of patients prior to or early during induction therapy, with special emphasis on FDG non-avid tumors...
  8. ncbi request reprint PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial
    Florian Lordick
    Department of Surgery, Clinic rechts der Isar, Technical University of Munich, Munich, Germany
    Lancet Oncol 8:797-805. 2007
    ..We aimed to assess the feasibility of a PET-response-guided treatment algorithm and its potential effect on prognosis...
  9. doi request reprint [(11)C]Choline positron emission tomography/computed tomography for staging and restaging of patients with advanced prostate cancer
    Murat Tuncel
    Department of Nuclear Medicine, Klinikum rechts der lsar, Technische Universitat Munchen, Munich, Germany
    Nucl Med Biol 35:689-95. 2008
    ..To evaluate [(11)C]Choline positron emission tomography (PET)/computed tomography (CT) for staging and restaging of patients with advanced prostate cancer and to compare the diagnostic performance of PET, CT and PET/CT...
  10. doi request reprint A pilot study to evaluate 3'-deoxy-3'-18F-fluorothymidine pet for initial and early response imaging in mantle cell lymphoma
    Ken Herrmann
    Department of Nuclear Medicine, Technische Universitat Munchen, Munich, Germany
    J Nucl Med 52:1898-902. 2011
    ..Immunohistochemical analysis from core biopsy or lymph node may not represent the proliferation rate. We investigated the in vivo proliferation marker 3'-deoxy-3'-(18)F-fluorothymidine ((18)F-FLT) to characterize MCL...
  11. doi request reprint (18)F-FDG PET-guided salvage neoadjuvant radiochemotherapy of adenocarcinoma of the esophagogastric junction: the MUNICON II trial
    Christian Meyer Zum Büschenfelde
    3rd Department of Medicine Haematology and Medical Oncology, Klinikum rechts der Isar, Technische Universitat Munchen, Munich, Germany
    J Nucl Med 52:1189-96. 2011
    ..Therefore, we initiated this prospective trial to improve the clinical outcome of metabolic nonresponders using a salvage neoadjuvant radiochemotherapy...
  12. doi request reprint [11C]Choline as pharmacodynamic marker for therapy response assessment in a prostate cancer xenograft model
    Bernd J Krause
    Department of Nuclear Medicine, Klinikum rechts der Isar, Technische Universitat Munchen, Ismaninger Str 22, 81675 Munchen, Munich, Germany
    Eur J Nucl Med Mol Imaging 37:1861-8. 2010
    ..11)C]Choline has been established as a PET tracer for imaging prostate cancer. The aim of this study was to determine whether [(11)C]choline can be used for monitoring the effects of therapy in a prostate cancer mouse xenograft model...
  13. doi request reprint The predictive value of metabolic response to preoperative radiochemotherapy in locally advanced rectal cancer measured by PET/CT
    Robert Rosenberg
    Chirurgische Klinik und Poliklinik, Klinikum rechts der Isar der Technischen Universitat Munchen, Ismaningerstr 22, 81675, Munich, Germany
    Int J Colorectal Dis 24:191-200. 2009
    ....
  14. doi request reprint Molecular imaging of proliferation in vivo: positron emission tomography with [18F]fluorothymidine
    Andreas K Buck
    Nuklearmedizinische Klinik und Poliklinik, Klinikum rechts der Isar der Technischen Universitat Munchen, Ismaninger Strasse 22, D 81675 Munich, Germany
    Methods 48:205-15. 2009
    ..Methods for in vivo assessment of the proliferative activity in preclinical and clinical studies are described with a focus on early monitoring response to therapy...
  15. doi request reprint Imaging proliferation to monitor early response of lymphoma to cytotoxic treatment
    Nicolas Graf
    Department of Hematology and Oncology, Technische Universitat Munchen, Ismaninger Strasse 22, 81675, Munich, Germany
    Mol Imaging Biol 10:349-55. 2008
    ..In this preclinical study, we have investigated if FLT can also be utilized for imaging therapy-induced alterations of the nucleoside metabolism and if FLT is a surrogate marker for early response to cytotoxic treatment...
  16. doi request reprint Phenotyping of tumor biology in patients by multimodality multiparametric imaging: relationship of microcirculation, alphavbeta3 expression, and glucose metabolism
    Stephan Metz
    Department of Radiology, Technische Universitat Munchen, Munich, Germany
    J Nucl Med 51:1691-8. 2010
    ..We analyzed the spatial relationship of α(v)β(3) expression, glucose metabolism, and perfusion by PET and DCE MRI, focusing on tumor heterogeneity...
  17. doi request reprint FLT-PET is superior to FDG-PET for very early response prediction in NPM-ALK-positive lymphoma treated with targeted therapy
    Zhoulei Li
    Nuclear Medicine, III Medical Department, Technische Universitat Munchen, Munich, Germany
    Cancer Res 72:5014-24. 2012
    ..In conclusion, we show that FLT-PET but not FDG-PET is able to predict response to treatment with specific inhibitors very early in the course of treatment and thus enables early prediction of treatment efficacy...
  18. ncbi request reprint Imaging gastric cancer with PET and the radiotracers 18F-FLT and 18F-FDG: a comparative analysis
    Ken Herrmann
    Department of Nuclear Medicine, Technische Universitat Munchen, Munich, Germany
    J Nucl Med 48:1945-50. 2007
    ..In this pilot study, we evaluated 3'-deoxy-3'-(18)F-fluorothymidine (FLT) PET for the detection of gastric cancer and compared the diagnostic accuracy with that of (18)F-FDG PET...
  19. ncbi request reprint Comparison of integrin alphaVbeta3 expression and glucose metabolism in primary and metastatic lesions in cancer patients: a PET study using 18F-galacto-RGD and 18F-FDG
    Ambros J Beer
    Department of Nuclear Medicine, Klinikum rechts der Isar, Technische Universitat Munchen, Munich, Germany
    J Nucl Med 49:22-9. 2008
    ..We evaluated whether assessment of alpha(v)beta(3) expression and of glucose metabolism with PET using (18)F-galacto-RGD and (18)F-FDG provides complementary information in cancer patients...
  20. doi request reprint Economic evaluation of PET and PET/CT in oncology: evidence and methodologic approaches
    Andreas K Buck
    Nuklearmedizinische Klinik und Poliklinik, Klinikum rechts der Isar der Technischen Universitat Munchen, Munich, Germany
    J Nucl Med Technol 38:6-17. 2010
    ....
  21. pmc [68Ga]Pentixafor-PET/CT for imaging of chemokine receptor CXCR4 expression in multiple myeloma - Comparison to [18F]FDG and laboratory values
    Constantin Lapa
    Department of Nuclear Medicine, University Hospital Wurzburg, Oberdurrbacher Strasse 6, 97080 Wurzburg, Germany
    Theranostics 7:205-212. 2017
    ..However, selecting patients for CXCR4 directed therapies and prognostic stratification seem to be more relevant clinical applications for this novel imaging modality, rather than diagnostic imaging of myeloma...
  22. pmc Multiparametric MR and PET Imaging of Intratumoral Biological Heterogeneity in Patients with Metastatic Lung Cancer Using Voxel-by-Voxel Analysis
    Stephan Metz
    Department of Radiology of the Technische Universitaet Muenchen, Munich, Germany
    PLoS ONE 10:e0132386. 2015
    ..Here, we present a solution to analyze and visualize the relationship between the apparent diffusion coefficient (ADC) and glucose metabolism on a spatially resolved voxel-by-voxel basis using dedicated quantitative software...
  23. doi request reprint Protein expression profiling in esophageal adenocarcinoma patients indicates association of heat-shock protein 27 expression and chemotherapy response
    Rupert Langer
    Institute of Pathology, Klinikum rechts der Isar, Technische Universitat Munchen, Munich, Germany
    Clin Cancer Res 14:8279-87. 2008
    ....
  24. pmc Somatostatin receptor expression in small cell lung cancer as a prognostic marker and a target for peptide receptor radionuclide therapy
    Constantin Lapa
    Department of Nuclear Medicine, University Hospital Wurzburg, 97080 Wurzburg, Germany
    Oncotarget 7:20033-40. 2016
    ..However, in patients exhibiting sufficient tracer uptake, PRRT might be a treatment option given its low toxicity and the absence of effective alternatives. ..
  25. doi request reprint Intraoperative 3-D imaging improves sentinel lymph node biopsy in oral cancer
    Christina Bluemel
    Department of Nuclear Medicine, University Hospital Wurzburg, Oberdürrbacher Str 6, 97080, Wurzburg, Germany
    Eur J Nucl Med Mol Imaging 41:2257-64. 2014
    ....
  26. doi request reprint Diagnostic efficacy of [11C]choline positron emission tomography/computed tomography compared with conventional computed tomography in lymph node staging of patients with bladder cancer prior to radical cystectomy
    Tobias Maurer
    Department of Urology, Technische Universitat Munchen, Klinikum rechts der Isar, Munich, Germany
    Eur Urol 61:1031-8. 2012
    ..Current imaging techniques are of limited value for lymph node (LN) staging in bladder cancer (BCa) patients scheduled for radical cystectomy (RC)...
  27. ncbi request reprint Early response assessment using 3'-deoxy-3'-[18F]fluorothymidine-positron emission tomography in high-grade non-Hodgkin's lymphoma
    Ken Herrmann
    Department of Nuclear Medicine, Technische Universitat Munchen, Munich, Germany
    Clin Cancer Res 13:3552-8. 2007
    ....
  28. doi request reprint The sensitivity of [11C]choline PET/CT to localize prostate cancer depends on the tumor configuration
    Michael Souvatzoglou
    Department of Nuclear Medicine, Technische Universitat Munchen, Munchen, Germany
    Clin Cancer Res 17:3751-9. 2011
    ..To evaluate the dependency of the sensitivity of [(11)C]choline positron emission tomography/computed tomography (PET/CT) for detecting and localizing primary prostate cancer (PCa) on tumor configuration in the histologic specimen...
  29. doi request reprint Pancreatic and hepatobiliary cancers
    Andreas K Buck
    Nuklearmedizinische Klinik und Poliklinik, Technische Universitat Munchen, Munchen, Germany
    Methods Mol Biol 727:243-64. 2011
    ..This chapter focuses on the use of PET-CT in hepatobiliary and pancreatic cancers...
  30. doi request reprint Proteomic and metabolic prediction of response to therapy in gastrointestinal cancers
    Ken Herrmann
    Department of Nuclear Medicine, Klinikum rechts der Isar, Technische Universitat Munchen, Munchen, Germany
    Nat Clin Pract Gastroenterol Hepatol 6:170-83. 2009
    ..Tissue-based and blood-based molecular biomarkers are still subject to validation. Prediction of response to treatment could ultimately lead to an overall improvement in prognosis...
  31. doi request reprint Economic evaluation of PET and PET/CT in oncology: evidence and methodologic approaches
    Andreas K Buck
    Nuklearmedizinische Klinik und Poliklinik, Klinikum rechts der Isar der Technischen Universitat Munchen, Munich, Germany
    J Nucl Med 51:401-12. 2010
    ....
  32. doi request reprint 18F-FDG PET and 18F-FDG PET/CT for assessing response to therapy in esophageal cancer
    Bernd Joachim Krause
    Department of Nuclear Medicine, Technische Universitat Munchen, Munich, Germany
    J Nucl Med 50:89S-96S. 2009
    ..In the future, prospective randomized multicenter trials will have to be performed and research will address new imaging probes and innovative therapy regimens...
  33. pmc The impact of 177Lu-octreotide therapy on 99mTc-MAG3 clearance is not predictive for late nephropathy
    Rudolf A Werner
    Department of Nuclear Medicine, University Hospital Wurzburg, Wurzburg, Germany
    Oncotarget 7:41233-41241. 2016
    ..TER assessed by 99mTc-MAG3-clearance prior to and during PRRT is not suitable as early predictor of renal injury and an increased risk for late nephropathy...
  34. pmc 11C-Methionine-PET in Multiple Myeloma: Correlation with Clinical Parameters and Bone Marrow Involvement
    Constantin Lapa
    1 University Hospital Würzburg, Department of Nuclear Medicine, Wurzburg, Germany 4 Comprehensive Cancer Center Mainfranken, Wurzburg, Germany
    Theranostics 6:254-61. 2016
    ..Tracer uptake correlates with BM involvement, β2m and FLC levels and appears to be a more accurate marker of tumor burden and disease activity. ..
  35. pmc Tumor-associated macrophages in glioblastoma multiforme-a suitable target for somatostatin receptor-based imaging and therapy?
    Constantin Lapa
    Department of Nuclear Medicine, University Hospital Wurzburg, Wurzburg, Germany
    PLoS ONE 10:e0122269. 2015
    ..The aim of this study was to non-invasively assess SSTR2A expression of both glioma cells as well as macrophages in GBM...
  36. pmc Week one FLT-PET response predicts complete remission to R-CHOP and survival in DLBCL
    Ken Herrmann
    Department of Nuclear Medicine, Technische Universitat Munchen, Munich, Germany Department of Nuclear Medicine, Universitatsklinikum Wurzburg, Wurzburg, Germany these authors contributed equally to this work
    Oncotarget 5:4050-9. 2014
    ..In conclusion, very early FLT-PET in the course of R-CHOP chemotherapy is feasible and enables identification of patients at risk for treatment failure. ..
  37. doi request reprint Imaging bone and soft tissue tumors with the proliferation marker [18F]fluorodeoxythymidine
    Andreas K Buck
    Department of Nuclear Medicine, Technische Universitat Munchen, Munich, Germany
    Clin Cancer Res 14:2970-7. 2008
    ....
  38. doi request reprint SPECT/CT
    Andreas K Buck
    Department of Nuclear Medicine, Technische Universitat Munchen, Munchen, Germany
    J Nucl Med 49:1305-19. 2008
    ..This review highlights recent technical developments in integrated SPECT/CT systems and summarizes the current literature on potential clinical uses and future directions for SPECT/CT in cardiac, neurologic, and oncologic applications...
  39. doi request reprint In vivo characterization of proliferation for discriminating cancer from pancreatic pseudotumors
    Ken Herrmann
    Department of Nuclear Medicine, Technische Universitat Munchen, Munich, Germany
    J Nucl Med 49:1437-44. 2008
    ..We have determined the ability of PET with the thymidine analog 3'-deoxy-3'-(18)F-fluorothymidine (FLT) to detect pancreatic cancer and to differentiate malignant from benign pancreatic lesions...
  40. doi request reprint PET and PET-CT in esophageal and gastric cancer
    Hinrich A Wieder
    Department of Radiology, Klinikum rechts der Isar, Technische Universitat Munchen, Munchen, Germany
    Methods Mol Biol 727:59-76. 2011
    ..The role of FDG-PET in diagnosis, preoperative staging, monitoring of response to neoadjuvant therapy, and detection of disease recurrence is evaluated in this chapter...
  41. pmc 68Ga-PSMA-PET/CT in Patients With Biochemical Prostate Cancer Recurrence and Negative 18F-Choline-PET/CT
    Christina Bluemel
    From the Departments of Nuclear Medicine, Urology, and Radiation Oncology, University Hospital of Wurzburg, Würzburg Department of Radiation Oncology, Klinikum Ansbach, Ansbach Department of Nuclear Medicine, Technische Universitat Munchen, Munich, Germany Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, CA Department of Nuclear Medicine PET CT Oncologic and Endocrine Sections, Rovigo Hospital, Rovigo, Italy Department of Radiology, University Hospital of Wurzburg, Wurzburg, Germany Scintomics GmbH, Fürstenfeldbruck and Pharmaceutical Radiochemistry, Technische Universitat Munchen, Munich, Germany
    Clin Nucl Med 41:515-21. 2016
    ..Investigating the value of Ga-PSMA-PET/CT in biochemically recurring prostate cancer patients with negative F-choline-PET/CT...
  42. pmc Impact of 68Ga-PSMA PET/CT on salvage radiotherapy planning in patients with prostate cancer and persisting PSA values or biochemical relapse after prostatectomy
    Christina Bluemel
    Department of Nuclear Medicine, University Hospital Wurzburg, Wurzburg, Germany
    EJNMMI Res 6:78. 2016
    ..Patients with oligometastatic (≤5 lesions) PC underwent radiotherapy (RT), with the extent of the RT area and dose escalation being based on PET positivity...
  43. pmc 11C-Methionine-PET: a novel and sensitive tool for monitoring of early response to treatment in multiple myeloma
    Katharina Lückerath
    University Hospital Wuerzburg, Department of Nuclear Medicine, Wuerzburg, Germany
    Oncotarget 6:8418-29. 2015
    ..Early changes in MET-uptake have predictive potential regarding response and survival. MET-PET holds promise to individualize therapies in MM in future. ..
  44. doi request reprint (18) F-fluorodeoxyglucose positron emission tomography/computed tomography for the detection of recurrent bone and soft tissue sarcoma
    Akram Al-Ibraheem
    Department of Nuclear Medicine, Technische Universitat Munchen, Munich, Germany
    Cancer 119:1227-34. 2013
    ....
  45. doi request reprint Classification of HER2/neu status in gastric cancer using a breast-cancer derived proteome classifier
    Benjamin Balluff
    Department of Medicine II, Klinikum rechts der Isar, Technische Universität München, Munich, Germany
    J Proteome Res 9:6317-22. 2010
    ....
  46. ncbi request reprint Fusion of freehand SPECT and ultrasound: First experience in preoperative localization of sentinel lymph nodes
    Christina Bluemel
    Department of Nuclear Medicine, University Hospital of Wurzburg, Oberdürrbacher Str 6, 97080, Wurzburg, Germany
    Eur J Nucl Med Mol Imaging 43:2304-2312. 2016
    ..The aim of this prospective study was to evaluate a novel approach involving real-time fusion of freehand SPECT (fhSPECT) and ultrasound (US) for anatomical co-registration of SLNs...
  47. pmc [68Ga]Pentixafor-PET/CT for imaging of chemokine receptor 4 expression in small cell lung cancer--initial experience
    Constantin Lapa
    Department of Nuclear Medicine, University Hospital Wurzburg, Wurzburg, Germany
    Oncotarget 7:9288-95. 2016
    ..68Ga]Pentixafor as a novel PET tracer might serve as readout for confirmation of CXCR4 expression as prerequisite for potential CXCR4-directed treatment including receptor-radio(drug)peptide therapy...
  48. ncbi request reprint Initial Preclinical Evaluation of 18F-Fluorodeoxysorbitol PET as a Novel Functional Renal Imaging Agent
    Hiroshi Wakabayashi
    Department of Nuclear Medicine, University of Wurzburg, Wurzburg, Germany
    J Nucl Med 57:1625-1628. 2016
    ..Furthermore, it can be synthesized via simple reduction of widely available 18F-FDG. We tested the feasibility of 18F-FDS renal PET imaging in rats...
  49. doi request reprint Sympathetic nerve damage and restoration after ischemia-reperfusion injury as assessed by (11)C-hydroxyephedrine
    Rudolf A Werner
    Department of Nuclear Medicine, University of Wurzburg, Oberdurrbacher Strasse 6, 97080, Wurzburg, Germany
    Eur J Nucl Med Mol Imaging 43:312-8. 2016
    ..The aim of this study was to investigate regional sympathetic nerve damage and restoration utilizing a rat model of myocardial transient ischemia and a catecholamine analog PET tracer, (11)C-hydroxyephedrine ((11)C-HED)...
  50. doi request reprint Freehand SPECT-guided sentinel lymph node biopsy in early oral squamous cell carcinoma
    Christina Bluemel
    Department of Nuclear Medicine, University Hospital of Wurzburg, Wurzburg, Germany
    Head Neck 36:E112-6. 2014
    ....
  51. pmc In vivo molecular imaging of chemokine receptor CXCR4 expression in patients with advanced multiple myeloma
    Kathrin Philipp-Abbrederis
    III Medical Department of Hematology and Medical Oncology, Technische Universitat Munchen, Munich, Germany
    EMBO Mol Med 7:477-87. 2015
    ....
  52. doi request reprint First demonstration of 3-D lymphatic mapping in breast cancer using freehand SPECT
    Thomas Wendler
    Technische Universitat Munchen, Boltzmannstr 3, 85748 Garching bei Muenchen, Germany
    Eur J Nucl Med Mol Imaging 37:1452-61. 2010
    ..In this pilot study, the feasibility of freehand SPECT for 3-D lymphatic mapping in breast cancer was evaluated...
  53. ncbi request reprint Metabolic imaging predicts response, survival, and recurrence in adenocarcinomas of the esophagogastric junction
    Katja Ott
    Department of Surgery, Technische Universitaet Muenchen, Ismaningerstr 22, D 81675, Munich, Germany
    J Clin Oncol 24:4692-8. 2006
    ..The aim of this study was to prospectively validate these findings by using an a priori definition of metabolic response...
  54. doi request reprint Small-animal PET imaging of isolated perfused rat heart
    Tomohiko Yamane
    Department of Nuclear Medicine, University of Wurzburg, Wurzburg, Germany
    J Nucl Med 55:495-9. 2014
    ..Analysis of the isolated perfused rat heart by a high-resolution small-animal PET system may offer both reliable evaluation of cardiac tracer kinetics and tomographic images...
  55. doi request reprint Three-dimensional magnetic resonance imaging using single breath-hold k-t BLAST for assessment of global left ventricular functional parameters
    Jennifer Jaroni
    Department of Radiology, Klinikum rechts der Isar, Technische Universitat Munchen, Ismaninger Str 22, 81675 Munich, Germany
    Acad Radiol 20:987-94. 2013
    ....
  56. doi request reprint EANM practice guidelines for lymphoscintigraphy and sentinel lymph node biopsy in melanoma
    Christina Bluemel
    Department of Nuclear Medicine, Universitatsklinikum Wurzburg, Wurzburg, Germany
    Eur J Nucl Med Mol Imaging 42:1750-66. 2015
    ..The aim of this document is to provide guidelines for nuclear medicine physicians performing lymphoscintigraphy for sentinel lymph node detection in patients with melanoma...
  57. doi request reprint Textural Parameters of Tumor Heterogeneity in ¹⁸F-FDG PET/CT for Therapy Response Assessment and Prognosis in Patients with Locally Advanced Rectal Cancer
    Ralph A Bundschuh
    Nuklearmedizinische Klinik und Poliklinik, Klinikum rechts der Isar der Technischen Universitat Munchen, Munich, Germany Klinik und Poliklinik für Nuklearmedizin, Universitatsklinikum Wurzburg, Wuerzburg, Germany Klinik und Poliklinik für Nuklearmedizin, Universitatsklinikum Bonn, Bonn, Germany
    J Nucl Med 55:891-7. 2014
    ..We investigated textural parameters for their predictive and prognostic capability in patients with rectal cancer using histopathology as the gold standard. In addition, a comparison to clinical outcome was performed...
  58. doi request reprint Comparison of the amino acid tracers 18F-FET and 18F-DOPA in high-grade glioma patients
    Constantin Lapa
    Department of Nuclear Medicine, University Hospital Wurzburg, Wurzburg, Germany
    J Nucl Med 55:1611-6. 2014
    ..The aim of this study was to determine whether (18)F-FET and (18)F-DOPA PET/CT provide comparable information in HGG...
  59. pmc Disclosing the CXCR4 expression in lymphoproliferative diseases by targeted molecular imaging
    Hans Jurgen Wester
    1 Pharmaceutical Radiochemistry, Technische Universitat Munchen, Garching, Germany
    Theranostics 5:618-30. 2015
    ....
  60. pmc 68Gallium- and 90Yttrium-/ 177Lutetium: "theranostic twins" for diagnosis and treatment of NETs
    Rudolf A Werner
    Department of Nuclear Medicine, Universitatsklinikum Wurzburg, Oberdürrbacher Str 6, 97080, Wurzburg, Germany
    Ann Nucl Med 29:1-7. 2015
    ....
  61. doi request reprint Pan-histone deacetylase inhibitor panobinostat sensitizes gastric cancer cells to anthracyclines via induction of CITED2
    Ivonne Regel
    Department of Medicine II, Universitat Munchen, Munchen, Germany
    Gastroenterology 143:99-109.e10. 2012
    ..Histone deacetylase (HDAC) inhibitors modify chromatin and can block cancer cell proliferation and promote apoptosis...
  62. pmc 18F-FDG-PET/CT Imaging as an early survival predictor in patients with primary high-grade soft tissue sarcomas undergoing neoadjuvant therapy
    Ken Herrmann
    Division of Surgical Oncology, University of California at Los Angeles, 10833 Le Conte Avenue, Rm 54 140 CHS, Los Angeles, CA 90095, USA
    Clin Cancer Res 18:2024-31. 2012
    ..We prospectively evaluated whether 2[18F]fluoro-2-deoxy-d-glucose ((18)F-FDG)-PET/computed tomographic (CT) imaging after the initial cycle of neoadjuvant therapy could predict overall survival in these patients...
  63. doi request reprint iROLL: does 3-D radioguided occult lesion localization improve surgical management in early-stage breast cancer?
    Christina Bluemel
    Department of Nuclear Medicine, University Hospital of Wurzburg, Oberdürrbacher Str 6, 97080, Wurzburg, Germany
    Eur J Nucl Med Mol Imaging 42:1692-9. 2015
    ....
  64. doi request reprint Sentinel lymph node biopsy in oral and oropharyngeal squamous cell carcinoma: current status and unresolved challenges
    Christina Bluemel
    Department of Nuclear Medicine, University Hospital of Wurzburg, Oberdürrbacher Str 6, 97080, Wurzburg, Germany
    Eur J Nucl Med Mol Imaging 42:1469-80. 2015
    ..This review gives an update on SLN biopsy in patients with OSCC including clinical standards and controversial aspects. ..